WebApr 5, 2024 · Currently, Dynavax Technologies Corp’s price-earnings ratio is 5.1. Dynavax Technologies Corp’s trailing 12-month revenue is $722.7 million with a 40.5% profit margin. Year-over-year quarterly sales growth most recently was -5.4%. Analysts expect adjusted earnings to reach $-0.504 per share for the current fiscal year. WebFeb 4, 2024 · Information on Dynavax's website at www.dynavax.com is not incorporated by reference in our current periodic reports with the SEC. Contacts: Nicole Arndt, Senior Manager, Investor Relations...
Is Dynavax Technologies Corporation (DVAX) Stock a Good …
WebMar 10, 2024 · Investor Relations Dynavax Technologies Corp DVAX Financial Information Morningstar Rating Rating as of Mar 10, 2024 Quote Chart Stock Analysis News Price vs Fair Value ... WebFeb 24, 2024 · Starting with revenue. Total revenue for 2024 was $723 million compared to $439 million for 2024, representing an annual increase of about 64%, which was driven both by HEPLISAV-B as well as CpG ... first page of watchmen
Dynavax and Serum Institute of India Announce First Participant Dosed …
WebApr 10, 2024 · See the latest Dynavax Technologies Corp stock price (NASDAQ:DVAX), related news, valuation, dividends and more to help you make your investing decisions. WebDVAX Earnings Date Earnings Per Share Estimated Reported Quarterly Earnings Surprise Amount Yearly Earnings Forecast Quarterly Earnings Forecast Change in Consensus … WebNov 6, 2024 · Welcome to the Dynavax third-quarter 2024 financial results and corporate update conference call. Joining me on the call today are Ryan Spencer, chief executive officer; Michael Ostrach, chief... first page pro สมัครงาน